Atlas Capital Advisors LLC Abb Vie Inc. Transaction History

Atlas Capital Advisors LLC

$656 Billion
Q3 2024

A detailed history of Atlas Capital Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 1,406 shares of ABBV stock, worth $253,080. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,406

Previous 7,106 80.21%

Holding current value

$253,080

Previous $1.22 Billion 77.22%

% of portfolio

0.04%

Previous 0.16%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$163.84 - $199.33 $933,888 - $1.14 Million	-5,700 Reduced 80.21%	1,406 $278 Million
Q2 2024 Jul 29, 2024	BUY	$154.79 - $180.76 $882,303 - $1.03 Million	5,700 Added 405.41%	7,106 $1.22 Billion
Q1 2024 Apr 15, 2024	SELL	$159.82 - $182.1 $910,974 - $1.04 Million	-5,700 Reduced 80.21%	1,406 $256 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $6,946 - $8,041	-52 Reduced 0.73%	7,106 $1.06 Billion
Q2 2023 Aug 15, 2023	SELL	$132.51 - $164.9 $14,973 - $18,633	-113 Reduced 1.55%	7,158 $964 Million
Q4 2022 Feb 15, 2023	SELL	$138.31 - $165.87 $1,798 - $2,156	-13 Reduced 0.18%	7,271 $1.18 Billion
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $22,815 - $26,168	-170 Reduced 2.28%	7,284 $978 Million
Q2 2022 Aug 16, 2022	BUY	$137.62 - $174.96 $65,507 - $83,280	476 Added 6.82%	7,454 $1.14 Billion
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $3,695 - $4,585	-28 Reduced 0.4%	6,978 $1.13 Billion
Q4 2021 Feb 01, 2022	SELL	$107.43 - $135.93 $158,244 - $200,224	-1,473 Reduced 17.37%	7,006 $949 Million
Q3 2021 Oct 28, 2021	BUY	$106.4 - $120.78 $189,285 - $214,867	1,779 Added 26.55%	8,479 $914,000
Q2 2021 Jul 30, 2021	BUY	$105.21 - $117.21 $7,364 - $8,204	70 Added 1.06%	6,700 $754,000
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $17,391 - $19,145	170 Added 2.63%	6,630 $717,000
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $64,633 - $87,262	-803 Reduced 11.06%	6,460 $692,000
Q3 2020 Oct 23, 2020	SELL	$85.91 - $100.83 $16,924 - $19,863	-197 Reduced 2.64%	7,263 $636,000
Q2 2020 Jul 28, 2020	BUY	$73.37 - $98.18 $107,120 - $143,342	1,460 Added 24.33%	7,460 $732,000
Q3 2019 Nov 01, 2019	SELL	$62.98 - $75.72 $14,422 - $17,339	-229 Reduced 3.68%	6,000 $454,000
Q1 2019 Apr 29, 2019	SELL	$77.14 - $90.79 $262,430 - $308,867	-3,402 Reduced 35.32%	6,229 $0
Q4 2018 Jan 29, 2019	SELL	$77.85 - $96.01 $418,832 - $516,533	-5,380 Reduced 35.84%	9,631 $887,000
Q3 2018 Nov 09, 2018	SELL	$88.91 - $98.84 $212,050 - $235,733	-2,385 Reduced 13.71%	15,011 $0
Q2 2018 Jul 30, 2018	BUY	$89.78 - $106.23 $200,837 - $237,636	2,237 Added 14.76%	17,396 $0
Q1 2018 Apr 18, 2018	BUY	$92.01 - $123.21 $1.39 Million - $1.87 Million	15,159 New	15,159 $0

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.

Account

Atlas Capital Advisors LLC Abb Vie Inc. Transaction History